Literature DB >> 2019997

Selective inhibition of potassium currents in rat ventricle by clofilium and its tertiary homolog.

N A Castle1.   

Abstract

The effects of clofilium and its tertiary homolog, LY97119 (LY), on K+ currents in isolated ventricular myocytes from adult rat were examined using the whole-cell patch-clamp technique. Acute exposure (less than 30 min) to high concentrations of clofilium (30-100 microM) produced a slowly developing reduction in the peak of the transient outward current (Ito) and an apparent increase in the rate of current inactivation. In addition, inhibition exhibited a marked dependence on the frequency of stimulation (i.e., use-dependent inhibition). For "short" exposure times (i.e., less than 30 min), steady-state inhibition was not attained. Therefore, myocytes were preincubated with clofilium for at least 3 hr before use. Under these conditions, the median inhibitory concentration for steady-state use-dependent inhibition of Ito was 0.5 microM. Recovery of Ito from use-dependent inhibition followed a biexponential time course; tau fast = 75 msec, tau slow = 17 sec. The relative magnitude of the slow component (but not its time constant) increased with higher clofilium concentrations. LY, like clofilium, also induced a time-dependent inhibition of Ito (median inhibiting concentration 0.9 microM). However, unlike clofilium, steady state with LY was reached within 5 min. Furthermore, LY (3 microM) produced very little use-dependent inhibition (29% at 1 Hz compared with 92% for clofilium). This is possibly due to a "fast" unbinding rate upon repolarization (tau = 1.8 s). In contrast to clofilium, LY (1-10 microM) also inhibited the inward rectifier (IK1). The present results suggest that inhibition of Ito may contribute to clofilium's class III antiarrhythmic action.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2019997

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  14 in total

1.  Distinct mechanisms of block of Kv1.5 channels by tertiary and quaternary amine clofilium compounds.

Authors:  J V Steidl; A J Yool
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

2.  Poster communications.

Authors: 
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

3.  An immunohistochemical and electrophysiological study on Isk protein in the stria vascularis of the guinea pig.

Authors:  N Mori; M Sakagami; K Fukazawa; T Matsunaga
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

4.  Mechanical and electrophysiological effects of 8-oxoberberine (JKL1073A) on atrial tissue.

Authors:  J F Chi; S H Chu; C S Lee; N K Chou; M J Su
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

5.  Proarrhythmic potential of halofantrine, terfenadine and clofilium in a modified in vivo model of torsade de pointes.

Authors:  Andrew J Batey; Susan J Coker
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

Review 6.  Ion Channels in Genetic Epilepsy: From Genes and Mechanisms to Disease-Targeted Therapies.

Authors:  Julia Oyrer; Snezana Maljevic; Ingrid E Scheffer; Samuel F Berkovic; Steven Petrou; Christopher A Reid
Journal:  Pharmacol Rev       Date:  2018-01       Impact factor: 25.468

7.  Effects of imipramine on the transient outward current in rabbit atrial single cells.

Authors:  E Delpón; J Tamargo; J Sánchez-Chapula
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

8.  Electrophysiological properties of human mesenchymal stem cells.

Authors:  Jürgen F Heubach; Eva M Graf; Judith Leutheuser; Manja Bock; Bartosz Balana; Ihor Zahanich; Torsten Christ; Sabine Boxberger; Erich Wettwer; Ursula Ravens
Journal:  J Physiol       Date:  2003-10-24       Impact factor: 5.182

9.  Antifibrillatory effects of clofilium in the rabbit isolated heart.

Authors:  G S Friedrichs; L Chi; A L Green; B R Lucchesi
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

10.  KCNT1 gain of function in 2 epilepsy phenotypes is reversed by quinidine.

Authors:  Carol J Milligan; Melody Li; Elena V Gazina; Sarah E Heron; Umesh Nair; Chantel Trager; Christopher A Reid; Anu Venkat; Donald P Younkin; Dennis J Dlugos; Slavé Petrovski; David B Goldstein; Leanne M Dibbens; Ingrid E Scheffer; Samuel F Berkovic; Steven Petrou
Journal:  Ann Neurol       Date:  2014-04-14       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.